Commission Implementing Regulation (EU) 2023/741 of 5 April 2023 concerning the n... (32023R0741)
Commission Implementing Regulation (EU) 2023/741 of 5 April 2023 concerning the non-renewal of the approval of the active substance oxamyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)
- COMMISSION IMPLEMENTING REGULATION (EU) 2023/741
- of 5 April 2023
- concerning the non-renewal of the approval of the active substance oxamyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
- (Text with EEA relevance)
- Article 1
- Non-renewal of the approval of the active substance
- Article 2
- Amendment to Implementing Regulation (EU) No 540/2011
- Article 3
- Transitional measures
- Article 4
- Grace period
- Article 5
- Entry into force
Feedback